Krebs Biochem.&Inds Stock Price Analysis and Quick Research Report. Is Krebs Biochem.&Inds an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Krebs Biochem.&Inds. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Krebs Biochem.&Inds has a PE ratio of -5.39053732725404 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Krebs Biochem.&Inds has ROA of -15.5176% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Krebs Biochem.&Inds has a Current ratio of 0.0991.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Krebs Biochem.&Inds has a ROE of 0%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Krebs Biochem.&Inds has a Debt to Equity ratio of -1.4511 which means that the company has low proportion of debt in its capital.

• Sales growth: Krebs Biochem.&Inds has reported revenue growth of -14.1003% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Krebs Biochem.&Inds for the current financial year is -34.700625001443%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Krebs Biochem.&Inds is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Krebs Biochem.&Inds is Rs -12.7427. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Krebs Biochem.&Inds in Ticker for free. Also, one can get the intrinsic value of Krebs Biochem.&Inds by using Valuation Calculators, which are available with a Finology ONE subscription. 

Krebs Biochem.&Inds FAQs

Q1. What is Krebs Biochem.&Inds share price today?
Ans: The current share price of Krebs Biochem.&Inds is Rs 68.69.

Q2. What is the market capitalisation of Krebs Biochem.&Inds?
Ans: Krebs Biochem.&Inds has a market capitalisation of Rs 148.099665234 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Krebs Biochem.&Inds?
Ans: The PE ratio of Krebs Biochem.&Inds is -5.39053732725404 and the P/B ratio of Krebs Biochem.&Inds is -0.939088445753253, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Krebs Biochem.&Inds share?
Ans: The 52-week high share price of Krebs Biochem.&Inds is Rs 129.07, and the 52-week low share price of Krebs Biochem.&Inds is Rs 65.55.

Q5. Does Krebs Biochem.&Inds pay dividends?
Ans: Currently, Krebs Biochem.&Inds does not pay dividends. Dividend yield of Krebs Biochem.&Inds is around 0%.

Q6. What are the face value and book value of Krebs Biochem.&Inds shares?
Ans: The face value of Krebs Biochem.&Inds shares is Rs 10, while the book value per share of Krebs Biochem.&Inds is around Rs -73.1454. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Krebs Biochem.&Inds?
Ans: Krebs Biochem.&Inds has a total debt of Rs 212.2084 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Krebs Biochem.&Inds?
Ans: The ROE of Krebs Biochem.&Inds is 0% and ROCE of Krebs Biochem.&Inds is -29.9223%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Krebs Biochem.&Inds a good buy for the long term?
Ans: The Krebs Biochem.&Inds long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Krebs Biochem.&Inds undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Krebs Biochem.&Inds appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Krebs Biochem.&Inds’s financials?
Ans: You can review Krebs Biochem.&Inds’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.